S.4109

Stem Cell Therapeutic and Research Reauthorization Act of 2026

Introduced·3/17/26

Reauthorizes the Stem Cell Therapeutic and Research Act of 2005 through 2031.

The Stem Cell Therapeutic and Research Reauthorization Act of 2026 extends the Stem Cell Therapeutic and Research Act of 2005 through 2031. It reauthorizes funding for the C.W. Bill Young Cell Transplantation Program and amends the Cord Blood Inventory. The bill ensures continued support for stem cell research and therapies, aiming to advance medical treatments and improve patient outcomes.

Included in complete analysis

  • Overview
  • Core Provisions
  • Implementation
  • Impact
  • Legal Framework
  • Critical Issues

See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.

Where it stands

Current
In committee
Next
Committee decision

Sponsors

Democratic CaucusRepublican Caucus

Calendar

Jun 17

10:00 AM

Senate Health, Education, Labor, and Pensions Hearing

History

Jun 22

Senate

Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.

Jun 22

Senate

Placed on Senate Legislative Calendar under General Orders. Calendar No. 443.

Jun 17

Senate

Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.